Cargando…

Impact of SGLT2 inhibitors on major clinical events and safety outcomes in heart failure patients: a meta-analysis of randomized clinical trials

BACKGROUND: Sodium-glucose co-transporter-2 inhibitors (SGLT2i) significantly reduce the risk of cardiovascular (CV) and renal adverse events in patients with diabetes mellitus, heart failure (HF) and/or chronic kidney disease. We performed a meta-analysis to explore the impact of several different...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bazoukis, George, Papadatos, Stamatis S., Thomopoulos, Costas, Tse, Gary, Cheilidis, Stefanos, Tsioufis, Konstantinos, Farmakis, Dimitrios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8558745/ https://www.ncbi.nlm.nih.gov/pubmed/34754290 http://dx.doi.org/10.11909/j.issn.1671-5411.2021.10.003

Ejemplares similares

The importance of inspection in clinical cardiology: Frank's sign
por: Bazoukis, George, et al.
Publicado: (2022)

Impact of ranolazine on ventricular arrhythmias – A systematic review
por: Bazoukis, George, et al.
Publicado: (2018)

Contemporary Role of Cardiac Magnetic Resonance in the Management of Patients with Suspected or Known Coronary Artery Disease
por: Bazoukis, George, et al.
Publicado: (2021)

Association of QT dispersion with mortality and arrhythmic events—A meta‐analysis of observational studies
por: Bazoukis, George, et al.
Publicado: (2019)

Diabetes Mellitus and Heart Failure: Epidemiology, Pathophysiologic Mechanisms, and the Role of SGLT2 Inhibitors
por: Theofilis, Panagiotis, et al.
Publicado: (2023)

Nontraumatic rhabdomyolysis with short-term alcohol intoxication – a case report
por: Papadatos, Stamatis S, et al.
Publicado: (2015)

Assessment and management of elemental mercury poisoning—a case report
por: Bazoukis, George, et al.
Publicado: (2017)

Acute Effects of Electronic and Tobacco Cigarette Smoking on Sympathetic Nerve Activity and Blood Pressure in Humans
por: Dimitriadis, Kyriakos, et al.
Publicado: (2022)

Safety of catheter ablation of atrial fibrillation without pre‐ or peri‐procedural imaging for the detection of left atrial thrombus in the era of uninterrupted anticoagulation
por: Efremidis, Michael, et al.
Publicado: (2020)

Machine learning versus conventional clinical methods in guiding management of heart failure patients—a systematic review
por: Bazoukis, George, et al.
Publicado: (2020)

Association between sodium-glucose cotransporter-2 inhibitors and incident atrial fibrillation/atrial flutter in heart failure patients with reduced ejection fraction: a meta-analysis of randomized controlled trials
por: Sfairopoulos, Dimitrios, et al.
Publicado: (2022)

Clinical effects of cardiac contractility modulation in heart failure with mildly reduced systolic function
por: Tschöpe, Carsten, et al.
Publicado: (2020)

The Therapeutic Role of SGLT-2 Inhibitors in Acute Heart Failure: From Pathophysiologic Mechanisms to Clinical Evidence with Pooled Analysis of Relevant Studies across Safety and Efficacy Endpoints of Interest
por: Patoulias, Dimitrios, et al.
Publicado: (2022)

Hyponatremia is associated with increased mortality in patients with acute decompensated hear failure
por: Vaitsis, J, et al.
Publicado: (2009)

Impact of SGLT2 Inhibitors on Heart Failure: From Pathophysiology to Clinical Effects
por: Palmiero, Giuseppe, et al.
Publicado: (2021)

An uncommon cause of inappropriate ICD shock
por: Bazoukis, George, et al.
Publicado: (2020)

Drug therapy for patients with systolic heart failure after the PARADIGM-HF trial: in need of a new paradigm of LCZ696 implementation in clinical practice
por: Filippatos, Gerasimos, et al.
Publicado: (2015)

Neglected nontoxic multinodular goiter presented as a large neck mass
por: Papadatos, Stamatis S., et al.
Publicado: (2016)

Efficacy and safety of SGLT2 inhibitors in heart failure: systematic review and meta‐analysis
por: Butler, Javed, et al.
Publicado: (2020)

SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice
por: Spatola, Leonardo, et al.
Publicado: (2017)

Clinical efficacy of SGLT2 inhibitors with different SGLT1/SGLT2 selectivity in cardiovascular outcomes among patients with and without heart failure: A systematic review and meta-analysis of randomized trials
por: Lee, Mei-Chuan, et al.
Publicado: (2022)

Cancer and Takotsubo syndrome: from rarity to clinical practice
por: Keramida, Kalliopi, et al.
Publicado: (2021)

Clinical significance, challenges and limitations in using artificial intelligence for electrocardiography-based diagnosis
por: Chung, Cheuk To, et al.
Publicado: (2022)

Genetic Predisposition to Cardiovascular Disease in Patients With Cancer: A Clinical Perspective
por: Farmakis, Dimitrios, et al.
Publicado: (2023)

Pancreatitis and myocarditis coexistence due to infection by Coxsackie B1 and B4 viruses
por: Lampropoulos, Konstantinos, et al.
Publicado: (2017)

Left Atrial Function Post Radiofrequency and Cryoballoon Ablation Assessed by Volume-Pressure Loops
por: Karanasos, Antonios, et al.
Publicado: (2022)

Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney
por: Giugliano, Dario, et al.
Publicado: (2020)

Inflammation and Heart Failure: Searching for the Enemy—Reaching the Entelechy
por: Paraskevaidis, Ioannis, et al.
Publicado: (2023)

Does SGLT1 inhibition add to the benefits of SGLT2 inhibition in the prevention and treatment of heart failure?
por: Pitt, Bertram, et al.
Publicado: (2022)

The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the “Ariadne's thread” for the “labyrinth” of COVID-19
por: Tsioufis, Costas, et al.
Publicado: (2020)

SGLT2 Inhibitors and Ketone Metabolism in Heart Failure
por: Saucedo-Orozco, Huitzilihuitl, et al.
Publicado: (2022)

Common surgical masks and unattended blood pressure changes in treated hypertensive patients
por: Konstantinidis, Dimitris, et al.
Publicado: (2022)

Effectiveness and Safety of SGLT2 Inhibitors in Clinical Routine Treatment of Patients with Diabetes Mellitus Type 2
por: Hopf, Maximilian, et al.
Publicado: (2021)

Safety and Efficacy of SGLT2 Inhibitors: A Multiple-Treatment Meta-Analysis of Clinical Decision Indicators
por: Martínez-Vizcaíno, Vicente, et al.
Publicado: (2021)

Editorial: Clinical prospective of SGLT2 inhibitors in atherosclerosis
por: Capuano, Annalisa, et al.
Publicado: (2022)

Heart Failure 2013
por: Giamouzis, Gregory, et al.
Publicado: (2013)

Rationale and Design of a Randomized Controlled Clinical Trial on the Safety and Efficacy of Flecainide versus Amiodarone in the Cardioversion of Atrial Fibrillation at the Emergency Department in Patients with Coronary Artery Disease (FLECA-ED)
por: Tsioufis, Panagiotis, et al.
Publicado: (2023)

Diuretics, SGLT2 inhibitors and falls in older heart failure patients: to prescribe or to deprescribe? A clinical review
por: van Poelgeest, Eveline P., et al.
Publicado: (2023)

Simple hematological predictors of AF recurrence in patients undergoing atrial fibrillation ablation
por: Bazoukis, George, et al.
Publicado: (2019)

Three‐dimensional electroanatomically guided slow pathway elimination is associated with procedural improvements and clinical benefit in atrioventricular node reentrant tachycardia patients
por: Tsiachris, Dimitrios, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0nfb1u1tjjm5n41vimq6omee69